RBC Capital Initiates Coverage On Solid Biosciences with Outperform Rating, Announces Price Target of $18

Benzinga · 2d ago
RBC Capital analyst Luca Issi initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Outperform rating and announces Price Target of $18.